Klocke Pharma-Service logo

Klocke Pharma-Service

Europe, Baden-Wurttemberg, Germany, Appenweier

Description

Klocke Pharma Service is a Pharmaceutical and Medicine Manufacturing company that works on manufacturing and contract packaging.

Investor Profile

Klocke Pharma-Service has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series D rounds (top funding stages).
  • Majority of deals are located in Germany.
  • Strong thematic focus on Aerospace, Air Transportation, Drones.

Stage Focus

  • Series D (100%)

Country Focus

  • Germany (100%)

Industry Focus

  • Aerospace
  • Air Transportation
  • Drones
  • Robotics
  • Transportation
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Klocke Pharma-Service frequently co-invest with?

Avala Capital
Europe, Berlin, Germany, Berlin
Co-Investments: 1
NTT Venture Capital
North America, California, United States, Menlo Park
Co-Investments: 1
Jericho Capital
North America, New York, United States, New York
Co-Investments: 1
b2venture
Europe, Berlin, Germany, Berlin
Co-Investments: 1
DB Schenker
Europe, Nordrhein-Westfalen, Germany, Essen
Co-Investments: 1
BlackRock
North America, New York, United States, New York
Co-Investments: 1
Mundys
Europe, Lazio, Italy, Rome
Co-Investments: 1
Geely
Asia, Zhejiang, China, Hangzhou
Co-Investments: 1
Intel Capital
North America, California, United States, Santa Clara
Co-Investments: 1
Continental
Europe, Niedersachsen, Germany, Hanover
Co-Investments: 1

What are some of recent deals done by Klocke Pharma-Service?

Volocopter

Bruchsal, Baden-Wurttemberg, Germany

Volocopter is an urban air mobility company that develops eco-friendly air taxis to transport people.

AerospaceAir TransportationDronesRoboticsTransportation
Series DMar 3, 2021
Amount Raised: $242,138,626